Patent Assignment
Reel/Frame 037181/0456
Assignment of Assignor's Interest
Recorded: 2015-12-01
Pages: 3
Assignee
PORTOLA PHARMACEUTICALS, INC.
270 E. GRAND AVE., SUITE 22, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates a Favorable Safety Profile and Evidence for Clinical Activity in Patients with Relapsed/Refractory B Cell Malignancies
Application:
62/168,530 →
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.